The $1.5 million injection provides near-term liquidity for a micro-cap company, but the structure is highly dilutive (preferred shares convertible at $1.67, plus up to 1,075,000 new warrants at $2.00). Monitor the shareholder vote in ~2 weeks — approval unlocks the conversion price increase to $2.00 and warrant repricing, which reduces immediate dilution risk but also enables the additional $1.0 million exercise. The $1.30 price condition for short-term warrant exercise is a key catalyst; if BNRG stays above $1.30, expect accelerated dilution. The cross-filing 20-F (annual report) provides context on the company's financial position and ongoing reliance on this funding source.
Price Chart
Executive Summary
Brenmiller Energy entered into Amendment No. 2 to its Securities Purchase Agreement with Alpha Capital Anstalt, securing an immediate $1.5 million investment through convertible preferred shares (initial conversion price $1.67, subject to increase to $2.00 upon shareholder approval) and warrants. The deal also provides for up to an additional $1.0 million from warrant exercises contingent on shareholder approval and a $1.30 share-price condition. Net proceeds will fund general corporate purposes, working capital, and commercial TES projects.
Key Facts
- Immediate $1.5 million investment via convertible preferred shares with initial conversion price of $1.67 per share.
- Conversion price may increase to $2.00 per share subject to shareholder approval.
- Company to issue pre-funded warrant for 75,000 shares, short-term warrants for 500,000 shares (expiring 1 week post-approval), and 5-year warrants for 500,000 shares, all at $2.00 exercise price, subject to shareholder approval.
- Alpha Capital agrees to exercise short-term warrants if 5-day VWAP before approval is at least $1.30, potentially adding $1.0 million.
- Shareholder meeting proxy must be filed within 14 days; Alpha Capital agrees to vote in favor.
- Exercise price of 1,700,000 existing warrants held by Alpha Capital reduced to $2.00 per share, effective upon shareholder approval.
- Net proceeds to be used for general corporate purposes, working capital, and commercial TES projects in Europe, U.S., and Middle East.
- Company has a market cap of approximately $3 million.
Financial Impact
Immediate $1.5 million preferred share investment, with potential additional $1.0 million from warrant exercises, totaling up to $2.5 million. Existing warrants on 1,700,000 shares repriced to $2.00.
Risk Factors
- Massive dilution from conversion of preferred shares and exercise of up to 1,075,000 new warrants at $2.00, plus repricing of 1,700,000 existing warrants to $2.00.
- Shareholder approval is required for key terms — failure to obtain approval could trigger adverse adjustments or renegotiation.
- The $1.30 price condition for short-term warrant exercise creates a binary event; if the stock trades below $1.30, the additional $1.0 million may not materialize.
- Company has a $3M market cap and is pre-revenue or early-stage — reliance on this single investor for capital is a concentration risk.
- Nasdaq continued listing standards may be at risk given the low market cap and repeated dilutive financings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-067568 |
| Document: ea0294397-6k_brenmiller.htm | 0001213900-26-067568 |
| Document: ea029439701ex10-2.htm | 0001213900-26-067568 |
| Document: ea029439701ex99-1.htm | 0001213900-26-067568 |
| Document: 0001213900-26-067568-index-headers.html | 0001213900-26-067568 |
| Document: 0001213900-26-067568-index.html | 0001213900-26-067568 |
| Document: 0001213900-26-067568.txt | 0001213900-26-067568 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 10w ago | 6-K | $3.46 | awaiting T+20 | awaiting T+20 | No price |
Jul 27, 2026 13w ago | 6-K | $0.5566 | awaiting T+20 | awaiting T+20 | No price |
Jul 27, 2026 13w ago | EFFECT | $0.5580 | awaiting T+20 | awaiting T+20 | No price |
Jul 10, 2026 15w ago | 6-K | $0.7240 $0.3951 | ▲ +45.43% | ▲ +48.61% | No price |
Jun 26, 2026 17w ago | EFFECT | $0.8052 $0.7815 | ▲ +2.94% | ▲ +4.20% | No price |
Jun 15, 2026 19w ago | EFFECT | $1.29 $0.7240 | ▲ +43.88% | ▲ +43.13% | No price |
Jun 11, 2026 19w ago | 6-K | $1.43 $0.8940 | ▼ −37.48% | ▼ −39.37% | No price |
Jun 2, 2026 21w ago | 6-K | $1.35 $0.8097 | ▲ +40.02% | ▲ +38.46% | No price |
May 18, 2026 23w ago | EFFECT | $1.72 $1.21 | ▲ +29.65% | ▲ +31.23% | No price |
Apr 27, 2026 26w ago | 6-K | $3.06 $1.59 | ▲ +48.04% | ▲ +53.51% | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers